ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO093

Caveolin-1 Protects Against AKI via Regulating Endoplasmic Reticulum Stress

Session Information

  • AKI: Mechanisms - I
    November 02, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms


  • Zhang, Yan, Xiangya Hospital Central South University, Changsha, Hunan, China
  • Peng, Zhangzhe, Xiangya Hospital Central South University, Changsha, Hunan, China

Acute renal injury (AKI) is a serious medical condition characterized by a rapid loss of renal function. Recent evidence has suggested that endoplasmic reticulum (ER) function is important for protein homeostasis (‘proteostasis’) in the kidney, and that ER stress is a component of acute kidney injury. Caveolin-1 (Cav1), a multifunctional membrane protein, is the main component of caveolae on the plasma membrane. Caveolae serve as a platform to regulate stress responses, cellular endocytosis, and signal transduction. Previous studies have shown that the expression of Cav1 was increased in AKI models induced by ischemia-reperfusion and gentamicin. However, the crucial role of Prdx1 in AKI remains unclear.


Cav1-deficient mice were used to determine its function and potential mechanisms in AKI.


In ischemic-reperfusion-induced AKI mice, a significant increase in the expression of Cav1 in kidney tissue was observed. Similar observations were also obtained in the lipopolysaccharide (LPS)-induced AKI mouse model. Likely, the expression of Cav-1 was increased in patients with AKI. Cav1 deficiency worsened renal function and caused more tubular injury in AKI induced by ischemia-reperfusion and LPS. Furthermore, i.p. injection of Cav1 peptide in Cav1-/- mice improves kidney function and attenuates kidney tubular injury in ischemic-reperfusion and LPS-induced AKI mice. Additionally, knockout of Cav1 aggravated endoplasmic reticulum stress and apoptosis in primary renal tubular epithelial cells.


Our results revealed that Cav1 may play a protective role in AKI by regulating ER stress, thereby identifying a novel and important therapeutic target for AKI.